Home › Journal › No. 2089 › Class 99 › Priority claimed from 08/09/2021; Application No. : 97017429 ;United States of America

Priority claimed from 08/09/2021; Application No. : 97017429 ;United States of America · application 5201052, class 99

Advertised in Trade Marks Journal No. 2089 on 30 January 2023. Opposition window closes 30 May 2023.

Priority claimed from 08/09/2021; Application No. : 97017429 ;United States of America

Application
5201052 · filed 23 September 2021
Class
Class 99:
Applicant
[International Registration No. : 1624564] (Company, foreign)
Use claimed
Proposed to be used
Advertised
Trade Marks Journal No. 2089, 30 January 2023

Is Priority claimed from 08/09/2021; Application No. : 97017429 ;United States of America trademarked? Every application under this name →

Goods or services claimed

IR DIVISION Cl.10;Diagnostic kits comprising of test tubes, collection containers and tools, and storage for collecting and shipping bodily fluids and tissue samples for use in disease testing. Cl.42;Providing an online internet website portal featuring links to scientific research data and information in the field of disease treatment and diagnosis and clinical trials; providing collected and analyzed medical and scientific research information in the field of genomics and medical treatment. Cl.44;Providing an internet website portal featuring information on patient medical test results from medical testing for diagnosis or treatment purposes; providing an internet website portal featuring links to medical information; genomic and genetic and molecular medical testing for cancer diagnostic or treatment purposes; providing collected and analyzed medical information on cancer genomics and treatment; providing collected and analyzed medical information on cancer genomics and treatment, for diagnostic and treatment purposes; medical testing for cancer diagnostic or treatment purposes; providing medical information and data to healthcare professionals on cancer genomics and treatment and clinical trials; providing medical information featuring the collection and analysis of cancer-associated genetics and treatments; providing medical data to healthcare professionals on cancer genomics and treatments and clinical trials.

Opposition window closes 30 May 2023. This mark has passed examination and is advertised so that anyone with an earlier right can object. A notice of opposition (Form TM-O) may be filed until that date; after it, the application proceeds to registration and the mark can only be challenged by rectification. Whether an opposition is worth filing depends on how close the marks are and whether the goods overlap: see how opposition works.

Similar marks in class 99, same issue

Found by the same matcher that powers Brand Watch: identical, contained, near-spellings and sounds-alike names.

What "advertised" means for Priority claimed from 08/09/2021; Application No. : 97017429 ;United States of America

Advertised is not registered. The Registry examined the application, found no bar (or the applicant overcame the objection), and published it. Registration follows only if no opposition is filed within four months, or if an opposition fails. Until the certificate issues, the applicant may use ™ but not ®. Our guide to trademark status meanings explains each stage, and how long registration takes gives realistic timelines.

Source and corrections. Details are reproduced as advertised by the Registrar of Trade Marks in the Trade Marks Journal (a public record) and may contain errors of transcription. Applicants may ask for a correction or removal of their entry by writing to mehak@trademarkindia.pro. This page is information, not legal advice and not a solicitation.

WhatsApp us